Read more about how Sterling can help you meet your environmental sustainability objectives through the responsible treatment of waste. https://hubs.li/Q02HCq880 #WasteTreatment #Environment #Sustainability #WeAreSterling
Sterling Pharma Solutions
Pharmaceutical Manufacturing
Cramlington, Tyne & Wear 15,685 followers
Sterling Pharma Solutions is a leading provider of API services to the pharmaceutical industry.
About us
Sterling Pharma Solutions is a global contract development and manufacturing organisation (CDMO) with 50 years’ experience in providing small molecule API development and manufacturing services to the pharmaceutical industry, specialising in handling challenging chemistries. Sterling manages the most complex API and API intermediate challenges from proof-of-concept to commercial manufacture, as well as Antibody Drug Conjugate (ADC) development and manufacturing services. Sterling believes that while science can be complex, partnerships should be simple. That’s why they have redefined the CDMO experience, marked by transparency, collaboration and trust; a Partnership Development and Manufacturing Organisation (PDMO®). Sterling has six facilities across the UK, USA and Europe, employing 1,350 people, including in Cramlington and Newcastle, UK; Deeside, Wales; Cork, Ireland, as well as North Carolina and Wisconsin in the US. Find out more: www.sterlingpharmasolutions.com/sterling-facilities
- Website
-
http://www.sterlingpharmasolutions.com
External link for Sterling Pharma Solutions
- Industry
- Pharmaceutical Manufacturing
- Company size
- 1,001-5,000 employees
- Headquarters
- Cramlington, Tyne & Wear
- Type
- Privately Held
- Founded
- 1969
- Specialties
- Chiral compounds, Custom manufacturing, Fluorination, Cryogenic, Hazardous chemistry, Continuous processing and scale-up, Controlled release, API development, API manufacturing, Drug substance, Drug substance development, Drug substance manufacturing, controlled substance APIs, Potent APIs, hazardous evaluation, material science, solid state chemistry , milling, micronisation, micronization, ADCs, Antibody Drug Conjugation, Bioconjugation, HPAPI, High Potency API, and Highly Potent API
Locations
Employees at Sterling Pharma Solutions
Updates
-
Applying a hydrogenation reaction to a flow chemistry apparatus allows for higher reaction temperatures and hydrogen pressures that would otherwise pose challenges on a large scale. Below, Research Scientist II, Joseph Mancinelli discusses how our North Carolina facility developed a process for hydrogenation reactions in flow chemistry. Click below to find out more. https://hubs.li/Q02HfcsH0 #Hydrogenation #FlowChemistry #CDMO #PDMO #WeAreSterling
-
-
In our latest Journey of an API blog, Operational Quality Department Manager, Donna Anderson discusses the role of quality control and quality assurance in API manufacturing, whilst also defining the key goals and strategies for success. Click below to read more. https://hubs.li/Q02GXng90 #QualityControl #QualityAssurance #DrugDevelopment #DrugManufacture #WeAreSterling
-
-
Knowledge gaps, impurity synthesis and process inefficiencies are all common challenges associated with technology transfers and project scale-up. Click below to discover how the right partner can help you overcome these challenges and maximise efficiency in your process. https://hubs.li/Q02GmhTR0 #CDMO #PDMO #DrugDevelopment #DrugManufacture #TechnologyTransfer #WeAreSterling
-
-
To streamline early phase discovery and development, and set their projects up for long-term success, organisations must carefully select an outsourcing partner with extensive early phase expertise. Click below to discover how the right partner can help you overcome key challenges during a project's early stages. https://hubs.li/Q02FyGD70 #DrugDevelopment #CDMO #PDMO #WeAreSterling
-
Catch up with the latest news from Sterling... 📰 Read about the expansion of our bioanalytical services offering at our dedicated UK bioconjugation facility 💻 Discover the key elements of successful pharmaceutical production as we continue following the journey of an API 👥 Meet Site Director of our Newcastle Biosphere site, Alistair Henderson 💭 Find out more about the stability of ADC toxins in sub-cellular fractions, from our Mass Spectrometry Manager, Christopher Nortcliffe 📄 Explore the use of peptides in the pharmaceutical industry with our experts Shane Madden, Peptide Process Manager and Tom Kiely, Senior Plant Engineer Click the link below to read the full newsletter. #CDMO #PDMO #DrugDevelopment #DrugManufacture #WeAreSterling
-
Below, our experts, Shane Madden, Peptide Process Manager and Tom Kiely, Senior Plant Engineer, take a look at the advances and core use cases for peptides in the pharmaceutical space. Click to read the full whitepaper. https://hubs.li/Q02DH8b10 #Peptides #CDMO #PDMO #DrugDevelopment #DrugManufacture #WeAreSterling
-
-
Our Cork facility recently welcomed work placement students from University College Cork and Munster Technological University to support their studies. The students are from a range of disciplines including chemistry, engineering and business. This provides students with a fantastic opportunity to gain valuable insights into the working world and apply their academic knowledge in practice. #StudentPlacement #WeAreSterling
-
-
Jonathan Welsh is responsible for method development and quality control analysis of large drug conjugates at our dedicated ADC facility in Deeside, Wales. Click below to read more about the importance of collaboration within his role as Senior Bioanalytical Scientist, and how this supports our customers' projects. https://hubs.li/Q02D8ZWb0 #CDMO #PDMO #WeAreSterling
-
-
Next week we will be exhibiting at World ADC Asia in Incheon, South Korea, between the 25th and 27th of June. Click the link below to book a meeting.👇 https://lnkd.in/djmb7rpQ #WorldADCAsia #CDMO #PDMO #DrugDevelopment #DrugManufacture #WeAreSterling